Biogen logo

Biogen (BIIB) Q1 2025 Earnings

BIIB·Reported May 1, 2025·Before market open

Biogen reported Q1 2025 revenue of $2.4B (+10.5% YoY), beat analyst consensus of $2.2B by $196.8M. Diluted EPS came in at $3.02 (-17.7% YoY), beat the $2.90 consensus by $0.12.

Revenue
$2.4Bbeat by $196.8M
Consensus: $2.2B
Diluted EPS
$3.02beat by $0.12
Consensus: $2.90
SEC

SEC Filings

Earnings release8-K · 0000875045-25-000014
Quarterly report10-Q · 0000875045-25-000018

Financial Snapshot

Trailing eight quarters through Q1 2025

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q1 2025 Earnings FAQ

Common questions about Biogen's Q1 2025 earnings report.

Biogen (BIIB) reported Q1 2025 earnings on May 1, 2025 before market open.

Biogen reported revenue of $2.4B and diluted EPS of $3.02 for Q1 2025.

Revenue beat the consensus estimate of $2.2B by $196.8M. EPS beat the consensus estimate of $2.90 by $0.12.

Compared to the same quarter a year prior, revenue grew 10.5% from $2.2B a year earlier and diluted EPS declined 17.7% from $3.67.

You can read the 8-K earnings release (0000875045-25-000014) and the 10-Q periodic report (0000875045-25-000018) directly on SEC EDGAR. The filing index links above go to sec.gov.